Arbejdsmarkedets Tillaegspension Invests $24.44 Million in Globe Life Inc. $GL

Arbejdsmarkedets Tillaegspension bought a new position in shares of Globe Life Inc. (NYSE:GLFree Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 174,761 shares of the company’s stock, valued at approximately $24,442,000. Globe Life makes up 0.6% of Arbejdsmarkedets Tillaegspension’s investment portfolio, making the stock its 25th largest position.

Other large investors also recently modified their holdings of the company. AQR Capital Management LLC grew its position in Globe Life by 98.6% in the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock valued at $174,340,000 after purchasing an additional 696,548 shares in the last quarter. Balyasny Asset Management L.P. bought a new position in Globe Life in the third quarter valued at $80,925,000. Westfield Capital Management Co. LP bought a new position in Globe Life in the third quarter valued at $61,569,000. Teachers Retirement System of The State of Kentucky grew its position in Globe Life by 2,617.6% in the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 182,215 shares of the company’s stock valued at $25,485,000 after purchasing an additional 175,510 shares in the last quarter. Finally, Comerica Bank grew its position in Globe Life by 865.4% in the third quarter. Comerica Bank now owns 152,662 shares of the company’s stock valued at $21,826,000 after purchasing an additional 136,849 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Stock Performance

Shares of GL stock opened at $154.44 on Friday. The stock has a market cap of $11.99 billion, a P/E ratio of 10.68 and a beta of 0.50. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. The company has a fifty day moving average price of $145.76 and a two-hundred day moving average price of $141.04. Globe Life Inc. has a one year low of $116.73 and a one year high of $156.69.

Globe Life (NYSE:GLGet Free Report) last announced its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). The firm had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.56 billion. Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The business’s revenue was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.07 EPS. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, equities analysts predict that Globe Life Inc. will post 15.56 EPS for the current year.

Globe Life Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be paid a $0.33 dividend. The ex-dividend date is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a yield of 0.9%. Globe Life’s dividend payout ratio (DPR) is currently 9.13%.

Analyst Ratings Changes

A number of research firms recently weighed in on GL. Weiss Ratings raised shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday. Texas Capital raised shares of Globe Life to a “strong-buy” rating in a research report on Wednesday, March 18th. Piper Sandler raised shares of Globe Life to a “strong-buy” rating in a research report on Thursday, April 2nd. JPMorgan Chase & Co. raised their target price on shares of Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Finally, Keefe, Bruyette & Woods reaffirmed a “moderate buy” rating and issued a $168.00 target price on shares of Globe Life in a research report on Thursday, March 26th. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Buy” and an average target price of $172.67.

Read Our Latest Analysis on Globe Life

Insider Transactions at Globe Life

In other Globe Life news, CEO James Matthew Darden sold 4,663 shares of the stock in a transaction on Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total value of $717,542.44. Following the completion of the sale, the chief executive officer owned 58,451 shares in the company, valued at $8,994,439.88. This trade represents a 7.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Frank M. Svoboda sold 12,500 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the sale, the chief executive officer owned 35,868 shares of the company’s stock, valued at approximately $5,192,969.04. This represents a 25.84% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 107,147 shares of company stock valued at $16,086,366. 2.11% of the stock is owned by company insiders.

Globe Life Company Profile

(Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Further Reading

Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GLFree Report).

Institutional Ownership by Quarter for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.